Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Frits Smit

1PUBLICATIONS
21CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Feb 08, 2024
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial).

Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel

Pageof 1

Frequent Collaborators

1 joint publications

Pim Hendriks

1 joint publications

Daphne D D Rietbergen

1 joint publications

Arian R van Erkel

1 joint publications

Minneke J Coenraad

1 joint publications

Mark J Arntz

1 joint publications

Andries E Braat

1 joint publications

Stijn Crobach

1 joint publications

Otto M van Delden

1 joint publications

Petra Dibbets-Schneider

1 joint publications

Tom van der Hulle

Frequent Collaborators

1 joint publications

Pim Hendriks

1 joint publications

Daphne D D Rietbergen

1 joint publications

Arian R van Erkel

1 joint publications

Minneke J Coenraad

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

433
See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

433
See more related videos